glp-1 controversy Government advisory on weight-loss drugs is a step forward, but is it enough? How will it curb misuse? I break down the key concerns on Health360, #Health360 #health360plus , Credit @indiatoday Serena Williams Is the Surprising

Using insights from our podcast series, Beyond the Scale: The Ozempic Effect , Drugwatch examines the complexities of insurance coverage, the role of health care providers and the risks of off-label use

Harm to our natural GLP-1 pathway

These medications work by reducing appetite and slowing digestion, which leads to significant weight loss in a relatively short period

While GHRP-2 primarily stimulates growth hormone release, which is known to aid fat metabolism and promote lipolysis (fat breakdown), it also significantly increases appetite and food intake

88 Increased expression of cerebral caspase-3 was observed in ischemia/reperfusion(I/R)-injured rats administered with oral EMPA, whereas apoptotic cells decreased, indicating that EMPA may help protect neurons